Smart Pills market size is projected to reach US$ 9,061.29 million by 2028 from US$ 4,019.30 million in 2021; it is estimated to grow at a CAGR of 12.3% during 2021–2028
The growth of the smart pills market is primarily due to the increase in strategic collaborations & partnerships on smart pills and rising demand for minimally invasive surgical procedures. However, the high cost of smart pills hampers the smart pills market's growth.
The COVID-19 pandemic led to an increase in smart pill tests and innovations due to industry players' constant endeavor towards developing products that could help in combating the disease. For instance, in November 2021, the UK approved a potentially game-changing SARS-CoV-2 antiviral pill to fight the Covid-19 pandemic. The drug molnupiravir was recommended by Britain’s MHRA (Medicines and Healthcare products Regulatory Agency) for use in people with mild to moderate COVID-19.
Download PDF Sample Copy at:
Based on application, the smart pills market is segmented into capsule endoscopy, drug delivery, and patient monitoring. In 2021, capsule endoscopy segment held the largest market share. However, drug delivery is estimated to grow at the fastest CAGR of 13.4% during the forecast period. Moreover, the capsule endoscopy segment is segmented into small bowel video capsule endoscopy, colon capsule endoscopy, controllable capsule endoscopy, storable capsule endoscopy, and other capsule endoscopy. In 2021, the small bowel video capsule endoscopy segment held the largest market share of the smart pills market by capsule endoscopy; however, colon capsule endoscopy is estimated to register the highest CAGR of 12.4% during the forecast period. The largest share of this segment is due to the higher preference for technological developments in the capsule endoscopes. Smart pills emerged as a revolutionary technological innovation, bridging digital technology and healthcare. The advent of these healthcare-cum-technological devices enabled addressing soaring demand for better monitoring and diagnostics.
CapsoVision, Inc.; Medtronic.; Check-Cap; PENTAX Medical; Olympus Corporation; BodyCap.; Otsuka America Pharmaceutical, Inc.; IntroMedic; Jinshan Science & Technology (Group) Co., Ltd.; and RF Co., Ltd. are a few leading companies operating in the smart pills market.
The report segments the smart pills market as follows:
Based on application, the smart pills market is segmented into capsule endoscopy, drug delivery, and patient monitoring. Based on disease indication, the market is segmented into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. Based on end user, the market is segmented into hospitals and clinics, research institutes, and home healthcare. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
About The Insight Partners:
The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Manufacturing and Construction, Technology, Chemicals and Materials.
We offer our clients multiple ways to customize research as per their specific needs and budget.
Contact us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-987
